Anxiety and depression are two of the most commonly reported psychiatric conditions among general populations, with around one in five individuals suffering from these conditions during their lives.
These conditions, more so than chronic pain, are actually the leading causes of disability worldwide. Almost 75% of people with mental disorders remain untreated in developing countries, with almost 1 million people taking their lives each year.In this module, we guide you through a range of symptoms and pathologies, and detail some of the more commonly observed psychiatric issues, from OCD to bipolar and Tourette’s. We review some traditional treatment options and then introduce a series of points of evidence that support the potential use of CBMPs for certain conditions.
Rounding off the module are some practical clinical operating points with regards to Anxiety & Depression management with CBMPs.